Literature DB >> 35182256

Elevated levels of sIL-2R, TNF-α and hs-CRP are independent risk factors for post percutaneous coronary intervention coronary slow flow in patients with non-ST segment elevation acute coronary syndrome.

Cheng Wang1, Yan Wu2, Yang Su1,3, Bin Mao1, Yihong Luo1, Yexiang Yan1, Kun Hu1, Yi Lu1, Wenliang Che4,5, Minying Wan6.   

Abstract

To evaluate the association between circulating levels of inflammatory cytokines and the occurrence of post-percutaneous coronary intervention (PCI) coronary slow flow (CSF) in patients with non-ST segment elevation acute coronary syndrome (NSTE-ACS). CSF after PCI commonly occurs and implies poor outcomes, while the determinants of post-PCI CSF in patients with NSTE-ACS remain controversial. In this multicenter case control study, 176 patients diagnosed with NSTE-ACS and with post-PCI CSF occurred composed of CSF group, while 352 matched NSTE-ACS patients composed control group. Corrected thrombolysis in myocardial infarction frame count (cTFC), circulating levels of inflammatory cytokines and PCI related parameters were analyzed using Logistic regression models. Among 528 patients with median age of 67 (59-76) and male proportion of 65.5%, 176 (35.0%) patients had occurrence of post-PCI CSF defined as cTFC ≥ 24. Patients with CSF presented more intense inflammatory activity revealed by higher levels of white blood cell, high-sensitivity C-reactive protein (hs-CRP), interleukin-1ß (IL-1ß), soluble IL-2 receptor (sIL-2R), IL-6, IL-8, IL-10 and tumor necrosis factor-α (TNF-α), while PCI related parameters were comparable. Correlation analysis showed cTFC was positively correlated with those inflammatory cytokines. Logistic regression model indicates that hs-CRP (odds ratio (OR) = 3.038, 95% confidence interval (CI) 1.545-5.975), sIL-2R (OR = 2.103, 95% CI 1.959-4.026) and TNF-α (OR = 3.708, 95% CI 1.426-9.641) were valuable predictors for CSF occurrence. Elevated circulating levels of inflammatory cytokine including hs-CRP, sIL-2R and TNF-α rather than PCI related parameters could predict post-PCI CSF in patients with NSTE-ACS.
© 2022. The Author(s).

Entities:  

Keywords:  Coronary slow flow (CSF); Inflammatory cytokines; Non-ST segment elevation acute coronary syndrome (NSTE-ACS); Percutaneous coronary intervention (PCI)

Year:  2022        PMID: 35182256     DOI: 10.1007/s10554-022-02529-8

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  38 in total

1.  Predictors and long-term prognosis of angiographic slow/no-reflow phenomenon during emergency percutaneous coronary intervention for ST-elevated acute myocardial infarction.

Authors:  Li Dong-bao; Hua Qi; Liu Zhi; Wang Shan; Jin Wei-ying
Journal:  Clin Cardiol       Date:  2010-12       Impact factor: 2.882

2.  Comparison of plaque characteristics in narrowings with ST-elevation myocardial infarction (STEMI), non-STEMI/unstable angina pectoris and stable coronary artery disease (from the ADAPT-DES IVUS Substudy).

Authors:  Liang Dong; Gary S Mintz; Bernhard Witzenbichler; D Christopher Metzger; Michael J Rinaldi; Peter L Duffy; Giora Weisz; Thomas D Stuckey; Bruce R Brodie; Kyeong Ho Yun; Ke Xu; Ajay J Kirtane; Gregg W Stone; Akiko Maehara
Journal:  Am J Cardiol       Date:  2015-01-14       Impact factor: 2.778

3.  Acute hyperglycemia is associated with adverse outcome after acute myocardial infarction in the coronary intervention era.

Authors:  Masaharu Ishihara; Sunao Kojima; Tomohiro Sakamoto; Yujiro Asada; Chuwa Tei; Kazuo Kimura; Shunichi Miyazaki; Masahiro Sonoda; Kazufumi Tsuchihashi; Masakazu Yamagishi; Yoshihiko Ikeda; Mutsunori Shirai; Hisatoyo Hiraoka; Takeshi Inoue; Fumio Saito; Hisao Ogawa
Journal:  Am Heart J       Date:  2005-10       Impact factor: 4.749

4.  Elevated level of plasma homocysteine in patients with slow coronary flow.

Authors:  Ali Riza Erbay; Hasan Turhan; Ayse Saatci Yasar; Selime Ayaz; Onur Sahin; Kubilay Senen; Hatice Sasmaz; Ertan Yetkin
Journal:  Int J Cardiol       Date:  2005-07-20       Impact factor: 4.164

5.  Increased plasma soluble adhesion molecules; ICAM-1, VCAM-1, and E-selectin levels in patients with slow coronary flow.

Authors:  Hasan Turhan; Gul Sevim Saydam; Ali Riza Erbay; Selime Ayaz; Ayse Saatci Yasar; Yuksel Aksoy; Nurcan Basar; Ertan Yetkin
Journal:  Int J Cardiol       Date:  2005-07-05       Impact factor: 4.164

Review 6.  Short-term effect of verapamil on coronary no-reflow associated with percutaneous coronary intervention in patients with acute coronary syndrome: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Qiang Su; Lang Li; Yangchun Liu
Journal:  Clin Cardiol       Date:  2013-06-07       Impact factor: 2.882

7.  Coronary Flow Assessment in Unstable Angina/non ST-segment Elevation Myocardial Infarction Patients via Thrombolysis in Myocardial Infarction Frame Count in Angiography.

Authors:  Hamidreza Sanati; Ali Zahedmehr; Ata Firouzi; Negar Salehi; Mohsen Maadani; Farshad Shakerian; Reza Kiani; Pedram Golnari; Sepideh Parchami-Ghazaee; Mohammadmehdi Peighambari
Journal:  Res Cardiovasc Med       Date:  2013-05-20

8.  Correlation IMA with TIMI frame count in slow coronary flow: can it be a guide for treatment?

Authors:  Naci Babat; Yuksel Kaya; Halit Demir
Journal:  Aging Male       Date:  2019-02-10       Impact factor: 5.892

9.  Plasma Choline as a Diagnostic Biomarker in Slow Coronary Flow.

Authors:  Yuan-Ting Zhu; Ling-Ping Zhu; Zhen-Yu Wang; Xue-Ting Qiu; Wan-Zhou Wu; Wei-Wang Liu; Yu-Yu Feng; Wen-Kai Xiao; Xin Luo; Zhen-Yu Li; Chuan-Chang Li
Journal:  Cardiol Res Pract       Date:  2020-01-25       Impact factor: 1.866

10.  Risk factors and angiographic profile of coronary slow flow (CSF) phenomenon in North Indian population: An observational study.

Authors:  Saibal Mukhopadhyay; Mitesh Kumar; Jamal Yusuf; Vinod Kumar Gupta; Sanjay Tyagi
Journal:  Indian Heart J       Date:  2017-09-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.